 | • レポートコード：MRC2012A6906 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ペプチドバイオシミラーの世界市場を広く調査・分析し、今後の市場展望をまとめております。ペプチドバイオシミラーの種類別市場規模（グルカゴン、カルシトニン）、用途別市場規模（腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sandoz、Mylan、Celltrion、Pfizer、Samsung Biologics、Teva Pahrmaceutical、Stada Arzneimittel AG、Amgen、Biocon、Dr. Reddy's Laboratories、 ・地域別グローバル市場分析 2015年-2020年 ・ペプチドバイオシミラーの北米市場（アメリカ、カナダ、メキシコ） ・ペプチドバイオシミラーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ペプチドバイオシミラーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ペプチドバイオシミラーの南米市場（ブラジル、アルゼンチン） ・ペプチドバイオシミラーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：グルカゴン、カルシトニン ・用途別分析：腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他疾患 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Peptides Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Peptides Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Peptides Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Peptides Biosimilars market has been segmented into
Glucagon
Calcitonin
By Application, Peptides Biosimilars has been segmented into:
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Peptides Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Peptides Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Peptides Biosimilars market.
The report offers in-depth assessment of the growth and other aspects of the Peptides Biosimilars market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Peptides Biosimilars Market Share Analysis
Peptides Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Peptides Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Peptides Biosimilars sales, revenue and market share for each player covered in this report.
The major players covered in Peptides Biosimilars are:
Sandoz
Mylan
Celltrion
Pfizer
Samsung Biologics
Teva Pahrmaceutical
Stada Arzneimittel AG
Amgen
Biocon
Dr. Reddy’s Laboratories
Among other players domestic and global, Peptides Biosimilars market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptides Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peptides Biosimilars, with price, sales, revenue and global market share of Peptides Biosimilars in 2018 and 2019.
Chapter 3, the Peptides Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptides Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Peptides Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Peptides Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Peptides Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peptides Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Glucagon
1.2.3 Calcitonin
1.3 Market Analysis by Application
1.3.1 Overview: Global Peptides Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Chronic Diseases
1.3.4 Autoimmune Diseases
1.3.5 Blood Disorders
1.3.6 Growth Hormone Deficiency
1.3.7 Infectious Diseases
1.3.8 Other Diseases
1.4 Overview of Global Peptides Biosimilars Market
1.4.1 Global Peptides Biosimilars Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sandoz
2.1.1 Sandoz Details
2.1.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sandoz SWOT Analysis
2.1.4 Sandoz Product and Services
2.1.5 Sandoz Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celltrion
2.3.1 Celltrion Details
2.3.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celltrion SWOT Analysis
2.3.4 Celltrion Product and Services
2.3.5 Celltrion Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Samsung Biologics
2.5.1 Samsung Biologics Details
2.5.2 Samsung Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Samsung Biologics SWOT Analysis
2.5.4 Samsung Biologics Product and Services
2.5.5 Samsung Biologics Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pahrmaceutical
2.6.1 Teva Pahrmaceutical Details
2.6.2 Teva Pahrmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pahrmaceutical SWOT Analysis
2.6.4 Teva Pahrmaceutical Product and Services
2.6.5 Teva Pahrmaceutical Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Stada Arzneimittel AG
2.7.1 Stada Arzneimittel AG Details
2.7.2 Stada Arzneimittel AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Stada Arzneimittel AG SWOT Analysis
2.7.4 Stada Arzneimittel AG Product and Services
2.7.5 Stada Arzneimittel AG Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biocon
2.9.1 Biocon Details
2.9.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biocon SWOT Analysis
2.9.4 Biocon Product and Services
2.9.5 Biocon Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dr. Reddy’s Laboratories
2.10.1 Dr. Reddy’s Laboratories Details
2.10.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Dr. Reddy’s Laboratories SWOT Analysis
2.10.4 Dr. Reddy’s Laboratories Product and Services
2.10.5 Dr. Reddy’s Laboratories Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Peptides Biosimilars Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Peptides Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Peptides Biosimilars Manufacturer Market Share in 2019
3.3.2 Top 6 Peptides Biosimilars Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Peptides Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Peptides Biosimilars Sales and Market Share by Regions (2015-2020)
4.1.2 Global Peptides Biosimilars Revenue and Market Share by Regions (2015-2020)
4.2 North America Peptides Biosimilars Sales and Growth Rate (2015-2020)
4.3 Europe Peptides Biosimilars Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Peptides Biosimilars Sales and Growth Rate (2015-2020)
4.5 South America Peptides Biosimilars Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Peptides Biosimilars Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Peptides Biosimilars Sales, Revenue and Market Share by Country
5.1.1 North America Peptides Biosimilars Sales and Market Share by Country (2015-2020)
5.1.2 North America Peptides Biosimilars Revenue and Market Share by Country (2015-2020)
5.2 United States Peptides Biosimilars Sales and Growth Rate (2015-2020)
5.3 Canada Peptides Biosimilars Sales and Growth Rate (2015-2020)
5.4 Mexico Peptides Biosimilars Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Peptides Biosimilars Sales, Revenue and Market Share by Country
6.1.1 Europe Peptides Biosimilars Sales and Market Share by Country (2015-2020)
6.1.2 Europe Peptides Biosimilars Revenue and Market Share by Country (2015-2020)
6.2 Germany Peptides Biosimilars Sales and Growth Rate (2015-2020)
6.3 UK Peptides Biosimilars Sales and Growth Rate (2015-2020)
6.4 France Peptides Biosimilars Sales and Growth Rate (2015-2020)
6.5 Russia Peptides Biosimilars Sales and Growth Rate (2015-2020)
6.6 Italy Peptides Biosimilars Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Peptides Biosimilars Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Peptides Biosimilars Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Peptides Biosimilars Revenue and Market Share by Regions (2015-2020)
7.2 China Peptides Biosimilars Sales and Growth Rate (2015-2020)
7.3 Japan Peptides Biosimilars Sales and Growth Rate (2015-2020)
7.4 Korea Peptides Biosimilars Sales and Growth Rate (2015-2020)
7.5 India Peptides Biosimilars Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Peptides Biosimilars Sales and Growth Rate (2015-2020)
7.7 Australia Peptides Biosimilars Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Peptides Biosimilars Sales, Revenue and Market Share by Country
8.1.1 South America Peptides Biosimilars Sales and Market Share by Country (2015-2020)
8.1.2 South America Peptides Biosimilars Revenue and Market Share by Country (2015-2020)
8.2 Brazil Peptides Biosimilars Sales and Growth Rate (2015-2020)
8.3 Argentina Peptides Biosimilars Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Peptides Biosimilars Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Peptides Biosimilars Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Peptides Biosimilars Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Peptides Biosimilars Sales and Growth Rate (2015-2020)
9.3 Turkey Peptides Biosimilars Sales and Growth Rate (2015-2020)
9.4 Egypt Peptides Biosimilars Sales and Growth Rate (2015-2020)
9.5 South Africa Peptides Biosimilars Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Peptides Biosimilars Sales and Market Share by Type (2015-2020)
10.2 Global Peptides Biosimilars Revenue and Market Share by Type (2015-2020)
10.3 Global Peptides Biosimilars Price by Type (2015-2020)
11 Global Peptides Biosimilars Market Segment by Application
11.1 Global Peptides Biosimilars Sales Market Share by Application (2015-2020)
11.2 Global Peptides Biosimilars Revenue Market Share by Application (2015-2020)
11.3 Global Peptides Biosimilars Price by Application (2015-2020)
12 Market Forecast
12.1 Global Peptides Biosimilars Sales, Revenue and Growth Rate (2021-2025)
12.2 Peptides Biosimilars Market Forecast by Regions (2021-2025)
12.2.1 North America Peptides Biosimilars Market Forecast (2021-2025)
12.2.2 Europe Peptides Biosimilars Market Forecast (2021-2025)
12.2.3 Asia-Pacific Peptides Biosimilars Market Forecast (2021-2025)
12.2.4 South America Peptides Biosimilars Market Forecast (2021-2025)
12.2.5 Middle East & Africa Peptides Biosimilars Market Forecast (2021-2025)
12.3 Peptides Biosimilars Market Forecast by Type (2021-2025)
12.3.1 Global Peptides Biosimilars Sales Forecast by Type (2021-2025)
12.3.2 Global Peptides Biosimilars Market Share Forecast by Type (2021-2025)
12.4 Peptides Biosimilars Market Forecast by Application (2021-2025)
12.4.1 Global Peptides Biosimilars Sales Forecast by Application (2021-2025)
12.4.2 Global Peptides Biosimilars Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Peptides Biosimilars Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Peptides Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Peptides Biosimilars Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sandoz Basic Information, Manufacturing Base and Competitors
Table 8. Sandoz Peptides Biosimilars Major Business
Table 9. Sandoz Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 10. Sandoz SWOT Analysis
Table 11. Sandoz Peptides Biosimilars Product and Services
Table 12. Sandoz Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Peptides Biosimilars Major Business
Table 15. Mylan Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 16. Mylan SWOT Analysis
Table 17. Mylan Peptides Biosimilars Product and Services
Table 18. Mylan Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Celltrion Basic Information, Manufacturing Base and Competitors
Table 20. Celltrion Peptides Biosimilars Major Business
Table 21. Celltrion Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 22. Celltrion SWOT Analysis
Table 23. Celltrion Peptides Biosimilars Product and Services
Table 24. Celltrion Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Peptides Biosimilars Major Business
Table 27. Pfizer Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Peptides Biosimilars Product and Services
Table 30. Pfizer Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 32. Samsung Biologics Peptides Biosimilars Major Business
Table 33. Samsung Biologics Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 34. Samsung Biologics SWOT Analysis
Table 35. Samsung Biologics Peptides Biosimilars Product and Services
Table 36. Samsung Biologics Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Pahrmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Teva Pahrmaceutical Peptides Biosimilars Major Business
Table 39. Teva Pahrmaceutical Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 40. Teva Pahrmaceutical SWOT Analysis
Table 41. Teva Pahrmaceutical Peptides Biosimilars Product and Services
Table 42. Teva Pahrmaceutical Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Stada Arzneimittel AG Basic Information, Manufacturing Base and Competitors
Table 44. Stada Arzneimittel AG Peptides Biosimilars Major Business
Table 45. Stada Arzneimittel AG Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 46. Stada Arzneimittel AG SWOT Analysis
Table 47. Stada Arzneimittel AG Peptides Biosimilars Product and Services
Table 48. Stada Arzneimittel AG Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Amgen Basic Information, Manufacturing Base and Competitors
Table 50. Amgen Peptides Biosimilars Major Business
Table 51. Amgen Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 52. Amgen SWOT Analysis
Table 53. Amgen Peptides Biosimilars Product and Services
Table 54. Amgen Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Biocon Basic Information, Manufacturing Base and Competitors
Table 56. Biocon Peptides Biosimilars Major Business
Table 57. Biocon Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 58. Biocon SWOT Analysis
Table 59. Biocon Peptides Biosimilars Product and Services
Table 60. Biocon Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Dr. Reddy's Laboratories Peptides Biosimilars Major Business
Table 63. Dr. Reddy's Laboratories Peptides Biosimilars Total Revenue (USD Million) (2017-2018)
Table 64. Dr. Reddy's Laboratories SWOT Analysis
Table 65. Dr. Reddy's Laboratories Peptides Biosimilars Product and Services
Table 66. Dr. Reddy's Laboratories Peptides Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Peptides Biosimilars Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Peptides Biosimilars Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Peptides Biosimilars Sales by Regions (2015-2020) (K MT)
Table 70. Global Peptides Biosimilars Sales Market Share by Regions (2015-2020)
Table 71. Global Peptides Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Peptides Biosimilars Sales by Countries (2015-2020) (K MT)
Table 73. North America Peptides Biosimilars Sales Market Share by Countries (2015-2020)
Table 74. North America Peptides Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Peptides Biosimilars Revenue Market Share by Countries (2015-2020)
Table 76. Europe Peptides Biosimilars Sales by Countries (2015-2020) (K MT)
Table 77. Europe Peptides Biosimilars Sales Market Share by Countries (2015-2020)
Table 78. Europe Peptides Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Peptides Biosimilars Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Peptides Biosimilars Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Peptides Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Peptides Biosimilars Sales by Countries (2015-2020) (K MT)
Table 83. South America Peptides Biosimilars Sales Market Share by Countries (2015-2020)
Table 84. South America Peptides Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Peptides Biosimilars Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Peptides Biosimilars Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Peptides Biosimilars Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Peptides Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Peptides Biosimilars Revenue Market Share by Countries (2015-2020)
Table 90. Global Peptides Biosimilars Sales by Type (2015-2020) (K MT)
Table 91. Global Peptides Biosimilars Sales Share by Type (2015-2020)
Table 92. Global Peptides Biosimilars Revenue by Type (2015-2020) (USD Million)
Table 93. Global Peptides Biosimilars Revenue Share by Type (2015-2020)
Table 94. Global Peptides Biosimilars Sales by Application (2015-2020) (K MT)
Table 95. Global Peptides Biosimilars Sales Share by Application (2015-2020)
Table 96. Global Peptides Biosimilars Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Peptides Biosimilars Market Share Forecast by Regions (2021-2025)
Table 98. Global Peptides Biosimilars Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Peptides Biosimilars Market Share Forecast by Type (2021-2025)
Table 100. Global Peptides Biosimilars Sales Forecast by Application (2021-2025)
Table 101. Global Peptides Biosimilars Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Peptides Biosimilars Picture
Figure 2. Global Sales Market Share of Peptides Biosimilars by Type in 2019
Figure 3. Glucagon Picture
Figure 4. Calcitonin Picture
Figure 5. Peptides Biosimilars Sales Market Share by Application in 2018
Figure 6. Oncology Picture
Figure 7. Chronic Diseases Picture
Figure 8. Autoimmune Diseases Picture
Figure 9. Blood Disorders Picture
Figure 10. Growth Hormone Deficiency Picture
Figure 11. Infectious Diseases Picture
Figure 12. Other Diseases Picture
Figure 13. Global Peptides Biosimilars Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Peptides Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Peptides Biosimilars Sales Market Share by Manufacturer in 2019
Figure 34. Global Peptides Biosimilars Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Peptides Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Peptides Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 39. Global Peptides Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Peptides Biosimilars Revenue Market Share by Regions (2015-2020)
Figure 41. Global Peptides Biosimilars Revenue Market Share by Regions in 2018
Figure 42. North America Peptides Biosimilars Sales and Growth Rate (2015-2020)
Figure 43. Europe Peptides Biosimilars Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Peptides Biosimilars Sales and Growth Rate (2015-2020)
Figure 45. South America Peptides Biosimilars Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Peptides Biosimilars Sales and Growth Rate (2015-2020)
Figure 47. North America Peptides Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Peptides Biosimilars Sales Market Share by Countries (2015-2020)
Figure 49. North America Peptides Biosimilars Sales Market Share by Countries in 2018
Figure 50. North America Peptides Biosimilars Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Peptides Biosimilars Revenue Market Share by Countries in 2018
Figure 52. United States Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Canada Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Mexico Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Europe Peptides Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Peptides Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Peptides Biosimilars Revenue Market Share by Countries in 2019
Figure 58. Germany Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 59. UK Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 60. France Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Russia Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Italy Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Asia-Pacific Peptides Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Peptides Biosimilars Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Peptides Biosimilars Revenue Market Share by Regions 2019
Figure 66. China Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Japan Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Korea Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 69. India Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Southeast Asia Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 71. South America Peptides Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Peptides Biosimilars Sales Market Share by Countries in 2019
Figure 73. South America Peptides Biosimilars Revenue Market Share by Countries in 2019
Figure 74. Brazil Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Argentina Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Middle East and Africa Peptides Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Peptides Biosimilars Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Peptides Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Peptides Biosimilars Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Egypt Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Turkey Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 83. South Africa Peptides Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Global Peptides Biosimilars Sales and Growth Rate (2021-2025) (K MT)
Figure 85. Global Peptides Biosimilars Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Peptides Biosimilars Market Forecast (2021-2025) (K MT)
Figure 87. Europe Sales Peptides Biosimilars Market Forecast (2021-2025) (K MT)
Figure 88. Asia-Pacific Sales Peptides Biosimilars Market Forecast (2021-2025) (K MT)
Figure 89. South America Sales Peptides Biosimilars Market Forecast (2021-2025) (K MT)
Figure 90. Middle East & Africa Sales Peptides Biosimilars Market Forecast (2021-2025) (K MT)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
G-CSF・G-CSFバイオシミラーの世界市場（～2026年） G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimu…- G-CSFバイオシミラーの世界市場（～2026年） Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are…
- 組換えペプチドの世界市場（～2026年） Market Analysis and Insights: Global Recombinant Peptides Market The global Recombinant Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Recombinant Peptides Scope and Market Size Recombinant Peptides market is…
- モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…
- 抗炎症ペプチドの世界市場（～2026年） Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal's skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and…